Of all the diagnoses in fertility medicine, azoospermia — the complete absence of sperm in the ejaculate — is perhaps the one that carries the heaviest immediate weight. When a man is told that his semen contains no sperm, the instinctive interpretation is final: biological fatherhood is not possible. The story is over before it began.
This interpretation is understandable. It is also, in a meaningful proportion of cases, incorrect.
Azoospermia is not a single condition. It is a clinical finding — zero sperm in the ejaculate — that can arise from two fundamentally different underlying mechanisms, each with a very different clinical meaning and a very different prognosis. For one of those mechanisms, biological fatherhood through modern assisted reproductive technology is not only possible — it is, with the right specialist and the right approach, achievable for the majority of affected men.
The procedures that make this possible — TESA and PESA, testicular and epididymal sperm retrieval — are available at Metro IVF in Ambikapur under the expertise of Dr. Ashish Soni. This article explains what they are, who they help, how they work, and what the stories of men who have gone from zero sperm count to fatherhood through these procedures look like — so that every couple facing this diagnosis can understand that the word azoospermia is not necessarily the last word in their story.
Understanding Azoospermia: Two Conditions, Not One
The clinical distinction that determines whether TESA or PESA can help is the distinction between the two types of azoospermia — obstructive and non-obstructive — and understanding this distinction is the foundation of every conversation about treatment.
Obstructive azoospermia occurs when sperm production in the testes is normal — or near normal — but a blockage somewhere along the reproductive tract prevents sperm from reaching the ejaculate. The sperm are being produced. They simply cannot get out.
The blockage can occur in several locations. The epididymis — the coiled tube where sperm mature and are stored before ejaculation — can become blocked by infection, by previous vasectomy, or by congenital absence of the vas deferens. The vas deferens itself — the tube that carries sperm from the epididymis to the urethra — can be blocked by surgical scarring, by previous hernia repair, or by congenital bilateral absence, a condition closely associated with cystic fibrosis gene mutations. The ejaculatory ducts can be blocked by cysts or inflammatory scarring.
In obstructive azoospermia, the prognosis for sperm retrieval is excellent. Because sperm production is normal, the testes contain sperm in the quantities expected for normal spermatogenesis. PESA — percutaneous epididymal sperm aspiration — or TESA — testicular sperm aspiration — can retrieve sperm directly from the epididymis or the testes, bypassing the blockage entirely. The retrieved sperm, used in ICSI, are capable of fertilizing eggs and producing viable embryos. Success rates for sperm retrieval in obstructive azoospermia are very high — sperm are found in the vast majority of cases — and IVF/ICSI outcomes using obstructive azoospermia-retrieved sperm are comparable to those using ejaculated sperm with normal parameters.
Non-obstructive azoospermia is different — and more complex. In non-obstructive azoospermia, the absence of sperm in the ejaculate is not due to a blockage but to impaired sperm production in the testes themselves. The testes are not making sperm in normal quantities, or are making very few sperm, or in the most severe cases are not making any mature sperm at all.
The causes of non-obstructive azoospermia include chromosomal conditions — Klinefelter syndrome, as described in the previous article, is the most common — Y chromosome microdeletions that remove the genetic material necessary for normal spermatogenesis, hormonal disorders, previous chemotherapy or radiation, mumps orchitis, and in some cases no identifiable cause at all.
Non-obstructive azoospermia is clinically more challenging than the obstructive form — but it is not necessarily hopeless. In many men with non-obstructive azoospermia, small focal areas of active spermatogenesis persist within the testes even when global sperm production is severely impaired. These focal areas cannot be accessed through standard TESA because they are not uniformly distributed — they exist in specific locations within the testicular tissue that can only be identified under surgical magnification. The procedure that accesses them — micro-TESE, microsurgical testicular sperm extraction — examines the testicular tissue under an operating microscope, identifies the areas where active spermatogenesis is occurring by their dilated, opaque tubular appearance, and selectively biopsies those specific areas to retrieve the sperm within them.
In men with non-obstructive azoospermia who undergo micro-TESE at specialized centers, sperm are found in approximately 40 to 60 percent of cases — meaning that biological fatherhood is possible for a substantial proportion of men who were told it was impossible, if the right surgical assessment is performed by a surgeon with the appropriate training and equipment.
PESA: What It Is and Who It Helps
PESA — percutaneous epididymal sperm aspiration — is the simpler and less invasive of the two primary sperm retrieval procedures. It is performed under local anesthesia or light sedation, takes approximately ten to fifteen minutes, and involves inserting a fine needle through the scrotal skin into the epididymis to aspirate the epididymal fluid in which stored sperm are suspended.
PESA is most appropriate for men with obstructive azoospermia where the blockage is in the epididymis or the vas deferens — including men who have had a vasectomy, men with congenital absence of the vas deferens, and men with epididymal blockage following infection. Because sperm production in these men is normal, the epididymis contains sperm in significant numbers, and PESA can retrieve an adequate sample for ICSI in the majority of cases.
The retrieved sperm are handed immediately to the embryologist, who assesses their motility and morphology and selects the best available sperm for injection into the partner's eggs. If excess sperm are retrieved — which is common in obstructive cases — they can be frozen for use in future cycles, avoiding the need for a repeat retrieval procedure.
PESA carries minimal risk — temporary discomfort at the aspiration site, resolving within a day or two, is the most common side effect. Serious complications are rare. Most men resume normal activities within forty-eight to seventy-two hours.
TESA: What It Is and Who It Helps
TESA — testicular sperm aspiration — retrieves sperm directly from the testicular tissue rather than from the epididymis. It is performed under local anesthesia or light sedation, involves inserting a needle into the testicular tissue and applying gentle suction to aspirate a small quantity of testicular tissue and fluid, and takes approximately fifteen to twenty minutes.
TESA is used both in obstructive azoospermia — when PESA has not retrieved adequate sperm from the epididymis — and in non-obstructive azoospermia — when the goal is to retrieve sperm directly from the testicular tissue where focal spermatogenesis may be occurring.
In obstructive cases, testicular sperm retrieval rates are high — comparable to epididymal retrieval. In non-obstructive cases, the retrieval rate varies depending on the underlying cause and the extent of spermatogenic impairment. Standard TESA — involving random needle aspiration without surgical magnification — retrieves sperm in approximately 20 to 30 percent of non-obstructive azoospermia cases. Micro-TESE — involving systematic examination of testicular tissue under an operating microscope — significantly improves this rate, retrieving sperm in 40 to 60 percent of appropriately selected non-obstructive cases.
An important advantage of testicular sperm compared to epididymal sperm is their lower DNA fragmentation content. Sperm that are retrieved directly from the testes have not yet undergone the epididymal transit during which oxidative DNA damage accumulates. In men with high ejaculatory sperm DNA fragmentation — whether or not they have azoospermia — testicular sperm retrieval produces sperm with significantly better DNA integrity, which translates into better embryo quality and improved IVF outcomes.
The Stories: From Zero Sperm to Fatherhood at Metro IVF
Suresh: Vasectomy Reversal Was Never the Answer He Needed
Suresh and Priya had their two children — both sons — and Suresh had undergone a vasectomy at age thirty-two. Several years later, the younger son was lost in a tragic accident. The grief that followed changed the shape of their family in ways they had not anticipated — including the emergence, over time, of a profound shared desire to have another child.
Suresh was forty-one. His vasectomy was nine years old. The option that had been suggested to them — vasectomy reversal surgery — carries a success rate that diminishes significantly with the time elapsed since the original vasectomy. At nine years, the probability of successful reversal producing adequate sperm in the ejaculate was significantly below 50 percent.
At Metro IVF, Dr. Soni assessed the clinical picture and recommended PESA as the most direct and reliable path. Rather than attempting to reverse the vasectomy — with its decreasing probability of success after nine years — and then waiting to see if ejaculated sperm returned, PESA could retrieve sperm directly from the epididymis, where they remained stored proximal to the vasectomy site, and proceed immediately to IVF with ICSI.
The PESA was performed on the same day as Priya's egg retrieval — coordinating the two procedures to allow fertilization on the same day. Motile sperm were retrieved from the epididymis in adequate numbers. Three of Priya's eggs fertilized. Two embryos reached blastocyst stage. The first blastocyst transferred resulted in a positive pregnancy test.
Their third son — the child whose arrival did not replace the one who was lost, but who completed the family in a way that Suresh and Priya had not known they still needed — was born the following year.
Suresh said, at a follow-up appointment, that the doctor who had suggested vasectomy reversal had never mentioned that another option existed. That PESA could retrieve sperm without reversing the vasectomy, and that the IVF cycle could proceed without waiting to see if the reversal worked.
He did not say this with anger. He said it with a matter-of-fact clarity that was its own kind of comment.
Mohan: The Diagnosis Nobody Made Until Metro IVF
Mohan was twenty-nine. He had been told at two clinics that his azoospermia meant biological fatherhood was not possible. He had been told this without a hormonal assessment. Without genetic testing. Without an ultrasound. Based on one semen analysis at each clinic.
He came to Metro IVF, he said, because his wife Sunita had refused to accept a conclusion reached without proper investigation. She had researched what a proper investigation of azoospermia should include, and she had determined that what Mohan had received at previous clinics was not it.
Dr. Soni's assessment of Mohan began with the clinical history — which revealed that Mohan had had bilateral undescended testes at birth, surgically corrected in early childhood through orchidopexy. This history — directly relevant to his azoospermia — had not been asked about at either previous clinic.
The hormonal profile showed moderately elevated FSH with low-normal testosterone — consistent with impaired spermatogenesis. Testicular volume was slightly reduced bilaterally but not severely so. Genetic testing revealed no Klinefelter syndrome and no Y chromosome microdeletion. The clinical picture was most consistent with non-obstructive azoospermia secondary to the bilateral cryptorchidism — the bilateral undescended testes in childhood had resulted in some degree of testicular damage despite surgical correction, producing impaired but not completely absent spermatogenesis.
The probability of finding sperm at standard TESA in non-obstructive azoospermia secondary to treated cryptorchidism is moderate — not as high as in obstructive cases, but not negligible. Dr. Soni discussed the realistic probabilities with Mohan and Sunita, clearly and without false reassurance.
TESA was performed. Sperm were found — present in small numbers, but motile and morphologically adequate for ICSI. Sunita underwent IVF stimulation. Three eggs were retrieved, two fertilized, and one developed to blastocyst stage. One blastocyst transferred — into a uterus that hysteroscopy had confirmed was normal — resulted in a positive pregnancy.
Mohan and Sunita's daughter was born at thirty-nine weeks. Mohan, who had been told biological fatherhood was not possible by two clinics before the investigation that found sperm in his testes, held her for the first time in the delivery ward and said nothing for several minutes.
He did not need to.
Rahul: When Normal Semen Analysis Wasn't the Whole Answer
This story differs from the previous two in an important way — Rahul was not azoospermic. His semen analysis showed a count within the normal range. But it is included here because it illustrates the value of TESA as a tool not only for azoospermia but for men with high sperm DNA fragmentation in their ejaculate.
Rahul and his wife Deepa had been through three IVF cycles. Each had produced embryos that looked morphologically normal. None had resulted in implantation. Deepa's evaluation at Metro IVF was comprehensive and revealed no clear female factor. Rahul's DFI — tested at Metro IVF for the first time — was 39 percent: severely elevated.
The clinical question was whether testicular sperm — which bypass the epididymal transit that accumulates DNA damage — would produce embryos with better developmental competence than ejaculated sperm with a DFI of 39 percent. The evidence supports TESA-sourced sperm in men with high ejaculatory DFI: testicular sperm in these men consistently show DFI levels of 10 to 15 percent, significantly below the ejaculatory level.
TESA was performed alongside Deepa's egg retrieval. Testicular sperm were retrieved and used for ICSI in place of the ejaculated sample. Four embryos were produced — one more than in any previous cycle. PGT-A confirmed two as euploid. The first euploid embryo transferred resulted in implantation.
Deepa is currently in her second trimester. Her three previous cycle failures had a single specific explanation — a level of sperm DNA fragmentation that compromised every embryo her previous cycles produced — and a single specific solution — testicular sperm that bypassed the source of that damage.
What the Investigation Before TESA or PESA Should Include
At Metro IVF, no man with azoospermia proceeds directly to sperm retrieval without a complete assessment that informs the clinical approach. This assessment is not merely procedural — it determines which retrieval technique is most appropriate, what the realistic probability of finding sperm is, and how the retrieved sperm should be used.
The assessment includes a clinical history covering childhood testicular history, previous surgeries, infections, medications, and any exposures affecting testicular function. It includes physical examination of the testes and epididymides — assessing volume, consistency, and the presence of epididymal fullness that suggests obstructive rather than non-obstructive azoospermia. It includes hormonal evaluation — FSH, LH, testosterone — with FSH in particular providing important prognostic information about spermatogenesis. It includes a scrotal Doppler ultrasound. And where the clinical picture suggests a genetic cause — elevated FSH, small testes, clinical features of Klinefelter syndrome, or the characteristic pattern suggesting Y chromosome microdeletion — genetic testing is performed before any retrieval is attempted.
This assessment is not performed to delay treatment. It is performed to ensure that the retrieval procedure chosen is appropriate, that the couple has realistic expectations about the probability of finding sperm, and that the decision to proceed is made with complete information.
The Message This Article Is Written to Deliver
If you or your partner has been told that azoospermia means biological fatherhood is not possible — this article has one message for you, and it is simple.
That conclusion may not have been reached with the investigation required to make it reliably.
A semen analysis that shows no sperm is not, on its own, sufficient to conclude that no sperm can be retrieved. The distinction between obstructive and non-obstructive azoospermia — which determines the probability of successful retrieval — requires a clinical assessment, a hormonal evaluation, and in many cases genetic testing, before it can be accurately made.
The men in this article — Suresh, Mohan, and the others whose stories are told in the article on male infertility — were told that biological fatherhood was not possible. They were told this without the investigation that would have revealed whether sperm could be retrieved. At Metro IVF, that investigation was performed. In each case, sperm were found. In each case, fatherhood followed.
Zero sperm in the ejaculate is not the same as zero sperm in the body. And zero sperm in the ejaculate, before a complete assessment has been performed, is not a verdict. It is the beginning of an investigation.
Your Next Step
If you have been told that azoospermia means fatherhood is not possible — or if you have a severely low sperm count that has been managed with standard approaches without success — a consultation with Dr. Ashish Soni at Metro IVF in Ambikapur will give you the most thorough, honest, and clinically complete assessment of what is actually possible for you.
That assessment will tell you whether you have obstructive or non-obstructive azoospermia. It will tell you what the realistic probability of sperm retrieval is with the appropriate technique. It will tell you, if sperm can be retrieved, what the IVF outcome data looks like for your specific presentation.
And in many cases — more than most couples who carry this diagnosis have been led to believe — it will tell you that the story is not over.
Metro IVF Test Tube Baby Center Ambikapur, Chhattisgarh metrofertility.in Led by Dr. Ashish Soni — North India's First Fertility Super Specialist
Zero sperm in the ejaculate is not the end of the story. Find out what is actually possible — book your consultation with Dr. Soni at Metro IVF today.